TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 29 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $364,000 | +40.5% | 774,603 | +108.4% | 0.00% | – |
| Q3 2016 | $259,000 | +68.2% | 371,705 | +380.2% | 0.00% | – |
| Q2 2016 | $154,000 | -86.6% | 77,406 | -39.6% | 0.00% | -100.0% |
| Q2 2015 | $1,149,000 | +73.3% | 128,069 | +22.1% | 0.00% | +200.0% |
| Q1 2015 | $663,000 | – | 104,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,227,832 | $856,000 | 0.04% |
| FT Options LLC | 15,000 | $10,000 | 0.01% |
| BLUESTEIN R H & CO LLC | 112,200 | $78,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 203,097 | $142,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 16,701 | $12,000 | 0.00% |
| Klingman & Associates, LLC | 10,000 | $7,000 | 0.00% |
| TFS CAPITAL LLC | 13,627 | $10,000 | 0.00% |
| OPPENHEIMER & CO INC | 75,500 | $53,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 103,900 | $72,000 | 0.00% |
| Virtu KCG Holdings LLC | 48,827 | $34,000 | 0.00% |